A twice-a-day pill for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is ...

High cholesterol is often the result of lifestyle factors like not getting enough exercise and eating a diet high in ...

AstraZenca is testing a once-daily PCSK9 inhibitor, currently known as AZD0780. After 12 weeks of use alongside standard ...

In a phase 2b study, treatment with a once-daily oral PCSK9 inhibitor added to statin therapy resulted in a more than 50% ...

New data from the PURSUIT Phase IIb trial reveal AstraZeneca‘s investigational oral PCSK9 inhibitor, AZD0780, delivers ...